The identification of monoclonal cryoglobulins (type I or type II with monoclonal IgM-RF) mandates a thorough evaluation for underlying hematological malignancies, including serum/urine immunofixation electrophoresis, serum free light chain assay, and bone marrow biopsy. The gene discussed is CD40LG; the disease is hematologic disorder.